Twist Bioscience stock edges higher to $101.83 as bullish trend continues and RSI nears overbought

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience edges higher today

Highlights

Twist Bioscience's Comp Viral panel enabled complete sequencing of the Bundibugyo Ebola virus where qPCR methods failed.
The company emphasized diagnostics capability in a real-world outbreak but did not alter its business outlook.
Shares opened with a strong gap up but retraced, with a 78% probability of further upside and an expected trading range of $92.1 to $111.55.

The company itself posted that its Comp Viral panel enabled complete genomic sequencing of the Bundibugyo Ebola virus in a recent outbreak after other qPCR-based methods failed to detect the virus. The post pointed to the application during the May 2026 Bundibugyo Virus Outbreak as a concrete instance of performance. This statement primarily illustrates the company’s diagnostics capabilities rather than signaling a direct change to its business outlook.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish structure maintained as early gap up fades amid overbought signals

The post gave traders nothing new to price in, so the session moved according to its technical cues. Shares of Twist Bioscience opened the day with a strong gap up, marking a notable jump early on, but much of those early gains were retraced as trading progressed. The chart shows the price maintaining a bullish structure by holding above its MA-20, MA-50, and MA-200, while overbought conditions are beginning to emerge with the RSI now at 62.4. Immediate focus is on whether the price can overcome the weekly high at $102.34, which acts as nearby resistance.

Weekly high in focus as probability favors continued upside

To determine if traders are recognizing the move, watch for price action relative to the weekly high at $102.34. The most notable development was the session’s gap up from $101.06 to $106.46, followed by a partial retracement. Even after a sustained move higher with a firm trend, for the coming trading week there is a 78% probability of further upside and 22% probability of downside, with an expected range between $92.1 and $111.55. A close above the weekly high would signal that buyers are following through, while a fall below $93.93 would suggest that the move is being faded. On the weekly chart, the longer-term picture stays firmly constructive.

Earlier, analysts noted that Twist Bioscience maintained a constructive technical outlook, supported by bullish momentum and strong trend signals. The latest demonstration of the company's diagnostic capabilities adds a new dimension to the story, with traders advised to monitor whether a sustained breakout above the weekly high at $102.34 can reinforce the prevailing upside scenario.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.